Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

Published:2019-02-26 Issue:2 Volume:14 Page:e0212989
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Motoya Satoshi,Watanabe Kenji,Ogata Haruhiko,Kanai Takanori,Matsui Toshiyuki,Suzuki Yasuo,Shikamura Mitsuhiro,Sugiura Kenkichi,Oda Kazunori,Hori Tetsuharu,Araki Takahiro,Watanabe Mamoru,Hibi Toshifumi^ORCID

Funder

Takeda Pharmaceutical Company

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Guidelines for the management of ulcerative colitis in Japan—developed through integration of evidence and consensus among experts;T Hibi;IBD Research,2010

2. Prevalence of ulcerative colitis and Crohn's disease in Japan;K Asakura;J Gastroenterol,2009

3. Impact of inflammatory bowel disease on Japanese patients’ quality of life: results of a patient questionnaire survey;F Ueno;J Gastroenterol,2017

4. Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial;BG Feagan;Aliment Pharmacol Ther,2017

5. Ulcerative colitis;I Ordás;Lancet

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning for Predicting Biologic Agent Efficacy in Ulcerative Colitis: An Analysis for Generalizability and Combination with Computational Models;Diagnostics;2024-06-21

2. Navigating the complexities of drug development for inflammatory bowel disease;Nature Reviews Drug Discovery;2024-05-22

3. Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis;Digestive Diseases and Sciences;2024-03-18

4. Comparative maintenance performance of all biologic agents and small molecules in ulcerative colitis: a network meta-analysis;European Journal of Gastroenterology & Hepatology;2024-03-12

5. Update for surgeons on novel induction treatments for acute severe inflammatory bowel disease associated colitis;ANZ Journal of Surgery;2024-03-07